$PVCT: PV-10 Data Presented by Moffitt Cancer Center Researchers Examines Induction of Systemic Immune Response in Multiple Tumor Types

Provectus issued a PR to circulate Moffitt's AACR poster. The poster is here. It is worthwhile to focus on Moffitt's Dr. Pilon-Thomas' quote in the PR.

"The findings of this study confirmed not only that PV-10 induces tumor-specific immunity after a single treatment with IL-PV-10 in multiple tumor types, but that the ablative process is critical for this in situ stimulation of the immune system. The data also show that T cells play a critical role in this response."